Encore Capital Group Inc
ECPG Nasdaq Short-Term Business Credit Institutions Financials FY2016βFY2025
What Encore Capital Group Inc does
No business description yet.
- Legal name
- ENCORE CAPITAL GROUP INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 25, 2026
- Accession Β· CIK
- 0001084961-26-000009
0001084961
Revenue and margins
Encore Capital Group Inc had $1.8B of revenue in fiscal 2025, up 34.4% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 15.6% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $127M in fiscal 2025, 7.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Encore Capital Group Inc returned $90.4M to shareholders in fiscal 2025, 71% of free cash flow. The diluted share count fell 1.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably Encore Capital Group Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $190M | $144M | $158M | $200M | $157M |
| Debt incl. finance leases | $3.1B | $2.9B | $3.4B | $3.7B | $4.0B |
| Net debt / EBITDA | 4.2x | 5.5x | 55.0x | 18.5x | 5.9x |
| Debt / equity | 2.6x | 2.5x | 3.6x | 4.8x | 4.1x |
| Interest coverage | 3.7x | 3.0x | 0.1x | 0.6x | 2.1x |
| Total assets | $4.6B | $4.5B | $4.6B | $4.8B | $5.3B |
| Total liabilities | $3.4B | $3.3B | $3.7B | $4.0B | $4.4B |
| Shareholders' equity | $1.2B | $1.2B | $937M | $767M | $977M |
| Net debt (β = net cash) | $2.9B | $2.8B | $3.2B | $3.5B | $3.9B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 3 / 7 | 6 / 7 | 6 / 7 | 6 / 7 | 6 / 7 | 5 / 7 | 3 / 7 | 4 / 7 | 6 / 7 |
| Accruals ratio | β1.5% | β1.0% | β1.6% | β1.6% | β2.1% | 1.0% | β0.4% | β7.9% | β6.3% | 2.0% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.1B | $1.1B | $1.3B | $1.4B | $1.5B | $1.6B | $1.4B | $1.2B | $1.3B | $1.8B |
| Operating income | $242M | $325M | $405M | $446M | $534M | $633M | $462M | $16.5M | $157M | $627M |
| Interest expense | $198M | $204M | $237M | $218M | $209M | $170M | $153M | $202M | $253M | $294M |
| Pretax income | $57.4M | $131M | $156M | $201M | $283M | $437M | $311M | β$180M | β$96.2M | $336M |
| Income tax | $38.2M | $52.0M | $46.8M | $32.3M | $70.4M | $85.3M | $116M | $26.2M | $43.0M | $79.3M |
| Net income | $76.6M | $83.2M | $116M | $168M | $212M | $351M | $195M | β$206M | β$139M | $257M |
| Diluted EPS | $2.96 | $3.15 | $4.06 | $5.33 | $6.68 | $11.26 | $7.46 | β$8.72 | β$5.83 | $10.91 |
| Diluted shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.02B | 0.02B | 0.02B |
| Cash flow | ||||||||||
| Cash from operations | $130M | $124M | $187M | $245M | $313M | $303M | $211M | $153M | $156M | $153M |
| Capital expenditure | $31.7M | $28.1M | $67.5M | $39.6M | $34.6M | $33.4M | $37.2M | $24.8M | $29.0M | $26.3M |
| Free cash flow | $98.7M | $95.7M | $119M | $205M | $278M | $270M | $173M | $128M | $127M | $127M |
| Depreciation and amortization | $34.9M | $40.0M | $41.2M | $41.0M | $42.8M | $50.1M | $46.4M | $41.7M | $32.4M | $28.8M |
| Stock-based compensation | $12.6M | $10.4M | $13.0M | $12.6M | $16.6M | $18.3M | $15.4M | $13.9M | $14.0M | $18.3M |
| Acquisitions | $0.7M | $96.4M | $0.0M | $0.0M | β | β | β | β | β | β |
| Share buybacks | $0.0M | $0.0M | β | $0.0M | $0.0M | $391M | $87.0M | $0.0M | $0.0M | $90.4M |
| Dividends and buybacks | $0.0M | $0.0M | β | $0.0M | $0.0M | $391M | $87.0M | $0.0M | $0.0M | $90.4M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $150M | $212M | $157M | $192M | $189M | $190M | $144M | $158M | $200M | $157M |
| Total debt | $2.9B | $3.5B | $3.6B | $3.6B | $3.4B | $3.1B | $2.9B | $3.4B | $3.7B | $4.0B |
| Finance lease liabilities | β | β | β | $8.1M | $8.3M | $7.0M | $5.7M | $2.8M | $1.1M | $0.6M |
| Property and equipment, net | $72.3M | $76.3M | $116M | $120M | $127M | $120M | $114M | $104M | $80.6M | $82.1M |
| Goodwill | $785M | $929M | $868M | $884M | $907M | $898M | $821M | $606M | $508M | $536M |
| Intangible assets | $28.2M | $75.7M | $60.6M | $51.4M | $45.0M | $36.3M | $22.1M | $0.0M | $0.0M | β |
| Total assets | $3.7B | $4.5B | $4.6B | $4.9B | $4.9B | $4.6B | $4.5B | $4.6B | $4.8B | $5.3B |
| Total liabilities | $3.1B | $3.8B | $3.8B | $3.9B | $3.6B | $3.4B | $3.3B | $3.7B | $4.0B | $4.4B |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $559M | $582M | $818M | $1.0B | $1.2B | $1.2B | $1.2B | $937M | $767M | $977M |
| Margins | ||||||||||
| Operating margin | 21.7% | 28.3% | 30.7% | 31.8% | 35.5% | 39.2% | 33.1% | 1.4% | 12.0% | 35.4% |
| EBITDA margin | 24.8% | 31.8% | 33.8% | 34.7% | 38.4% | 42.3% | 36.4% | 4.8% | 14.4% | 37.1% |
| Net margin | 6.9% | 7.3% | 8.8% | 11.9% | 14.1% | 21.7% | 13.9% | β16.9% | β10.6% | 14.5% |
| FCF margin | 8.9% | 8.4% | 9.0% | 14.6% | 18.5% | 16.7% | 12.4% | 10.5% | 9.7% | 7.2% |
| Returns | ||||||||||
| Return on capital | 4.8% | 5.4% | 6.7% | 8.5% | 9.1% | 12.6% | 7.6% | 0.3% | 2.9% | 9.9% |
| Return on equity | 13.7% | 14.6% | 16.6% | 18.2% | 18.9% | 29.2% | 16.5% | β19.5% | β16.3% | 29.5% |
| Return on assets | 2.1% | 2.0% | 2.5% | 3.5% | 4.3% | 7.4% | 4.3% | β4.5% | β3.0% | 5.1% |
| Return on tangible equity | β | β | β | 193.8% | 79.8% | 139.7% | 57.9% | β62.6% | β53.7% | 58.3% |
| Growth | ||||||||||
| Revenue growth | β | 2.9% | 15.3% | 6.5% | 6.8% | 7.5% | β13.4% | β12.6% | 7.7% | 34.4% |
| Net income growth | β | 8.7% | 39.2% | 44.9% | 26.2% | 65.6% | β44.5% | β206.1% | β | β |
| EPS growth | β | 6.4% | 28.9% | 31.3% | 25.3% | 68.6% | β33.7% | β216.9% | β | β |
| FCF growth | β | β3.0% | 24.7% | 71.9% | 35.7% | β3.1% | β35.7% | β26.1% | β0.8% | β0.2% |
| Share count change | β | 1.9% | 8.2% | 10.2% | 0.7% | β1.8% | β16.2% | β9.3% | 0.9% | β1.4% |
| Financial health | ||||||||||
| Net debt / EBITDA | 9.8x | 9.1x | 7.7x | 7.0x | 5.5x | 4.2x | 5.5x | 55.0x | 18.5x | 5.9x |
| Debt / equity | 5.1x | 6.1x | 4.4x | 3.5x | 2.8x | 2.6x | 2.5x | 3.6x | 4.8x | 4.1x |
| Interest coverage | 1.2x | 1.6x | 1.7x | 2.0x | 2.5x | 3.7x | 3.0x | 0.1x | 0.6x | 2.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.8% | 2.5% | 5.1% | 2.8% | 2.3% | 2.1% | 2.7% | 2.0% | 2.2% | 1.5% |
| Stock comp / revenue | 1.1% | 0.9% | 1.0% | 0.9% | 1.1% | 1.1% | 1.1% | 1.1% | 1.1% | 1.0% |
| Payouts / FCF | 0.0% | 0.0% | β | 0.0% | 0.0% | 144.8% | 50.2% | 0.0% | 0.0% | 71.2% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 3.0 | 6.0 | 6.0 | 6.0 | 6.0 | 5.0 | 3.0 | 4.0 | 6.0 |
| Accruals ratio | β1.5% | β1.0% | β1.6% | β1.6% | β2.1% | 1.0% | β0.4% | β7.9% | β6.3% | 2.0% |
Source: SEC EDGAR XBRL filings (CIK 0001084961). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.